Annual Operating Profit
-$20.62 M
-$7.08 M-52.30%
December 31, 2023
Summary
- As of February 8, 2025, EPRX annual operating income is -$20.62 million, with the most recent change of -$7.08 million (-52.30%) on December 31, 2023.
- During the last 3 years, EPRX annual operating profit has fallen by -$18.95 million (-1130.16%).
- EPRX annual operating profit is now -1130.16% below its all-time high of -$1.68 million, reached on December 1, 2020.
Performance
EPRX Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Profit
-$6.27 M
+$281.90 K+4.30%
September 1, 2024
Summary
- As of February 8, 2025, EPRX quarterly operating income is -$6.27 million, with the most recent change of +$281.90 thousand (+4.30%) on September 1, 2024.
- Over the past year, EPRX quarterly operating profit has increased by +$281.90 thousand (+4.30%).
- EPRX quarterly operating profit is now -4732.97% below its all-time high of -$129.80 thousand, reached on December 1, 2020.
Performance
EPRX Quarterly Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM Operating Profit
-$31.50 M
+$349.50 K+1.10%
September 1, 2024
Summary
- As of February 8, 2025, EPRX TTM operating income is -$31.50 million, with the most recent change of +$349.50 thousand (+1.10%) on September 1, 2024.
- Over the past year, EPRX TTM operating profit has increased by +$349.50 thousand (+1.10%).
- EPRX TTM operating profit is now -2542.18% below its all-time high of -$1.19 million, reached on September 1, 2019.
Performance
EPRX TTM Operating Profit Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Profit Formula
Operating Profit = Gross Profit − Operating Expenses
EPRX Operating Profit Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -52.3% | +4.3% | +1.1% |
| 3 y3 years | -1130.2% | -132.0% | -112.8% |
| 5 y5 years | -86.7% | -794.0% | -1327.5% |
EPRX Operating Profit Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -52.3% | at low | -132.0% | +47.6% | -135.0% | +1.1% |
| 5 y | 5-year | -1130.2% | at low | -4733.0% | +47.6% | -1993.0% | +1.1% |
| alltime | all time | -1130.2% | at low | -4733.0% | +47.6% | -2542.2% | +1.1% |
Eupraxia Pharmaceuticals Operating Profit History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$6.27 M(-4.3%) | -$31.50 M(-1.1%) |
| Jun 2024 | - | -$6.56 M(-2.1%) | -$31.85 M(+2.7%) |
| Mar 2024 | - | -$6.69 M(-44.1%) | -$31.00 M(+11.3%) |
| Dec 2023 | -$20.62 M(+52.3%) | -$11.98 M(+80.9%) | -$27.85 M(+20.9%) |
| Sep 2023 | - | -$6.62 M(+16.0%) | -$23.03 M(+15.4%) |
| Jun 2023 | - | -$5.71 M(+61.5%) | -$19.95 M(+5.0%) |
| Mar 2023 | - | -$3.54 M(-50.6%) | -$19.01 M(+4.5%) |
| Dec 2022 | -$13.54 M(-9.1%) | - | - |
| Dec 2022 | - | -$7.16 M(+102.2%) | -$18.19 M(+32.5%) |
| Sep 2022 | - | -$3.54 M(-25.7%) | -$13.73 M(-3.0%) |
| Jun 2022 | - | -$4.77 M(+75.5%) | -$14.16 M(+5.6%) |
| Mar 2022 | - | -$2.72 M(+0.5%) | -$13.40 M(-9.5%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2021 | -$14.90 M(+788.6%) | -$2.70 M(-31.9%) | -$14.80 M(+21.0%) |
| Sep 2021 | - | -$3.97 M(-1.1%) | -$12.23 M(+41.5%) |
| Jun 2021 | - | -$4.01 M(-2.5%) | -$8.64 M(+68.7%) |
| Mar 2021 | - | -$4.12 M(+3071.0%) | -$5.12 M(+199.7%) |
| Dec 2020 | -$1.68 M(-63.9%) | -$129.80 K(-66.1%) | -$1.71 M(-9.7%) |
| Sep 2020 | - | -$383.00 K(-22.6%) | -$1.89 M(-30.0%) |
| Jun 2020 | - | -$495.10 K(-29.4%) | -$2.70 M(+22.4%) |
| Mar 2020 | - | -$701.70 K(+124.3%) | -$2.21 M(+46.6%) |
| Dec 2019 | -$4.64 M(-58.0%) | -$312.80 K(-73.8%) | -$1.50 M(+26.2%) |
| Sep 2019 | - | -$1.19 M | -$1.19 M |
| Dec 2018 | -$11.05 M(+188.0%) | - | - |
| Dec 2017 | -$3.84 M | - | - |
FAQ
- What is Eupraxia Pharmaceuticals annual operating income?
- What is the all time high annual operating profit for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals annual operating profit year-on-year change?
- What is Eupraxia Pharmaceuticals quarterly operating income?
- What is the all time high quarterly operating profit for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals quarterly operating profit year-on-year change?
- What is Eupraxia Pharmaceuticals TTM operating income?
- What is the all time high TTM operating profit for Eupraxia Pharmaceuticals?
- What is Eupraxia Pharmaceuticals TTM operating profit year-on-year change?
What is Eupraxia Pharmaceuticals annual operating income?
The current annual operating profit of EPRX is -$20.62 M
What is the all time high annual operating profit for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high annual operating income is -$1.68 M
What is Eupraxia Pharmaceuticals annual operating profit year-on-year change?
Over the past year, EPRX annual operating income has changed by -$7.08 M (-52.30%)
What is Eupraxia Pharmaceuticals quarterly operating income?
The current quarterly operating profit of EPRX is -$6.27 M
What is the all time high quarterly operating profit for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high quarterly operating income is -$129.80 K
What is Eupraxia Pharmaceuticals quarterly operating profit year-on-year change?
Over the past year, EPRX quarterly operating income has changed by +$281.90 K (+4.30%)
What is Eupraxia Pharmaceuticals TTM operating income?
The current TTM operating profit of EPRX is -$31.50 M
What is the all time high TTM operating profit for Eupraxia Pharmaceuticals?
Eupraxia Pharmaceuticals all-time high TTM operating income is -$1.19 M
What is Eupraxia Pharmaceuticals TTM operating profit year-on-year change?
Over the past year, EPRX TTM operating income has changed by +$349.50 K (+1.10%)